Gui-Ping Chen, Zhen-Zhen Lu, Guan-Zhong Lu, Yi Zhou, San-Gang Wu
{"title":"粘膜相关淋巴组织淋巴瘤生存的流行病学研究:原发肿瘤部位的比较分析。","authors":"Gui-Ping Chen, Zhen-Zhen Lu, Guan-Zhong Lu, Yi Zhou, San-Gang Wu","doi":"10.1080/08941939.2025.2523858","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To investigate outcome and local treatment strategy for extranodal mucosa-associated lymphoid tissue (MALT) lymphoma patients.</p><p><strong>Methods: </strong>Retrospectively collected patients using the data from the Surveillance, Epidemiology, and End Results database, including tumor sites with over 200 cases.</p><p><strong>Results: </strong>The cohort comprised 3842 patients, with the gastric region being the most prevalent site (34.9%), followed by salivary gland (16.8%), cutaneous (16.5%), pulmonary (13.3%), intestinal (13.2%), and head and neck (5.4%). The 10-year cancer-specific survival (CSS) was 88.1%, 92.6%, 86.5%, 87.7%, 89.7%, and 97.7% in patients with tumors located in the gastric, salivary gland, pulmonary, head and neck, intestinal, and cutaneous, respectively (<i>p</i> < 0.001). Compared to gastric MALT lymphoma, the cutaneous site exhibited superior CSS (<i>p</i> < 0.001), whereas other sites showed comparable outcomes (all <i>p</i> ≥ 0.05). In gastric MALT lymphoma cases, radiotherapy was associated with better CSS than surgery alone (<i>p</i> < 0.001), while no significant difference was observed between surgery plus radiotherapy versus surgery alone (<i>p</i> = 0.561). Treatment outcomes were similar across the three therapeutic modalities for non-gastric sites.</p><p><strong>Conclusions: </strong>Our findings underscore the biological and clinical heterogeneity of extranodal MALT lymphoma. While localized treatments provide equivalent results across most non-gastric sites, radiotherapy is recommended as the primary noninvasive treatment option.</p>","PeriodicalId":16200,"journal":{"name":"Journal of Investigative Surgery","volume":"38 1","pages":"2523858"},"PeriodicalIF":2.1000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An Epidemiological Study on Survival in Lymphoma of Mucosa-Associated Lymphoid Tissue: A Comparative Analysis by Primary Tumor Location.\",\"authors\":\"Gui-Ping Chen, Zhen-Zhen Lu, Guan-Zhong Lu, Yi Zhou, San-Gang Wu\",\"doi\":\"10.1080/08941939.2025.2523858\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To investigate outcome and local treatment strategy for extranodal mucosa-associated lymphoid tissue (MALT) lymphoma patients.</p><p><strong>Methods: </strong>Retrospectively collected patients using the data from the Surveillance, Epidemiology, and End Results database, including tumor sites with over 200 cases.</p><p><strong>Results: </strong>The cohort comprised 3842 patients, with the gastric region being the most prevalent site (34.9%), followed by salivary gland (16.8%), cutaneous (16.5%), pulmonary (13.3%), intestinal (13.2%), and head and neck (5.4%). The 10-year cancer-specific survival (CSS) was 88.1%, 92.6%, 86.5%, 87.7%, 89.7%, and 97.7% in patients with tumors located in the gastric, salivary gland, pulmonary, head and neck, intestinal, and cutaneous, respectively (<i>p</i> < 0.001). Compared to gastric MALT lymphoma, the cutaneous site exhibited superior CSS (<i>p</i> < 0.001), whereas other sites showed comparable outcomes (all <i>p</i> ≥ 0.05). In gastric MALT lymphoma cases, radiotherapy was associated with better CSS than surgery alone (<i>p</i> < 0.001), while no significant difference was observed between surgery plus radiotherapy versus surgery alone (<i>p</i> = 0.561). Treatment outcomes were similar across the three therapeutic modalities for non-gastric sites.</p><p><strong>Conclusions: </strong>Our findings underscore the biological and clinical heterogeneity of extranodal MALT lymphoma. While localized treatments provide equivalent results across most non-gastric sites, radiotherapy is recommended as the primary noninvasive treatment option.</p>\",\"PeriodicalId\":16200,\"journal\":{\"name\":\"Journal of Investigative Surgery\",\"volume\":\"38 1\",\"pages\":\"2523858\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Investigative Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/08941939.2025.2523858\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Investigative Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/08941939.2025.2523858","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/30 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
摘要
目的:探讨结外粘膜相关淋巴组织(MALT)淋巴瘤患者的预后和局部治疗策略。方法:回顾性收集来自监测、流行病学和最终结果数据库的数据,包括200多例肿瘤部位的患者。结果:该队列共3842例患者,胃区是最常见的部位(34.9%),其次是唾液腺(16.8%)、皮肤(16.5%)、肺部(13.3%)、肠道(13.2%)和头颈部(5.4%)。肿瘤位于胃、唾液腺、肺、头颈部、肠道和皮肤的10年肿瘤特异性生存率(CSS)分别为88.1%、92.6%、86.5%、87.7%、89.7%和97.7% (p < 0.001)。与胃MALT淋巴瘤相比,皮肤部位表现出更好的CSS (p p≥0.05)。在胃MALT淋巴瘤病例中,放疗比单纯手术有更好的CSS (p p = 0.561)。非胃部位的三种治疗方式的治疗结果相似。结论:我们的研究结果强调结外MALT淋巴瘤的生物学和临床异质性。虽然局部治疗在大多数非胃部位提供相同的结果,但推荐放疗作为主要的非侵入性治疗选择。
An Epidemiological Study on Survival in Lymphoma of Mucosa-Associated Lymphoid Tissue: A Comparative Analysis by Primary Tumor Location.
Purpose: To investigate outcome and local treatment strategy for extranodal mucosa-associated lymphoid tissue (MALT) lymphoma patients.
Methods: Retrospectively collected patients using the data from the Surveillance, Epidemiology, and End Results database, including tumor sites with over 200 cases.
Results: The cohort comprised 3842 patients, with the gastric region being the most prevalent site (34.9%), followed by salivary gland (16.8%), cutaneous (16.5%), pulmonary (13.3%), intestinal (13.2%), and head and neck (5.4%). The 10-year cancer-specific survival (CSS) was 88.1%, 92.6%, 86.5%, 87.7%, 89.7%, and 97.7% in patients with tumors located in the gastric, salivary gland, pulmonary, head and neck, intestinal, and cutaneous, respectively (p < 0.001). Compared to gastric MALT lymphoma, the cutaneous site exhibited superior CSS (p < 0.001), whereas other sites showed comparable outcomes (all p ≥ 0.05). In gastric MALT lymphoma cases, radiotherapy was associated with better CSS than surgery alone (p < 0.001), while no significant difference was observed between surgery plus radiotherapy versus surgery alone (p = 0.561). Treatment outcomes were similar across the three therapeutic modalities for non-gastric sites.
Conclusions: Our findings underscore the biological and clinical heterogeneity of extranodal MALT lymphoma. While localized treatments provide equivalent results across most non-gastric sites, radiotherapy is recommended as the primary noninvasive treatment option.
期刊介绍:
Journal of Investigative Surgery publishes peer-reviewed scientific articles for the advancement of surgery, to the ultimate benefit of patient care and rehabilitation. It is the only journal that encompasses the individual and collaborative efforts of scientists in human and veterinary medicine, dentistry, basic and applied sciences, engineering, and law and ethics. The journal is dedicated to the publication of outstanding articles of interest to the surgical research community.